Senti Biosciences Holdings (SNTI) Profit After Tax (2021 - 2025)
Senti Biosciences Holdings (SNTI) recorded quarterly Profit After Tax of -$14.4 million in Q4 2025, up 20.4% quarter-over-quarter from -$18.1 million in Q3 2025, and down 2227.26% on a YoY basis from $678291.0 in Q4 2024.
Senti Biosciences Holdings (SNTI) Profit After Tax (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Profit After Tax history runs 5 years deep, the most recent figure standing at -$14.4 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 2227.26% year-over-year to -$14.4 million; the TTM figure through Dec 2025 stood at -$61.4 million (down 16.29% YoY), while the FY2025 annual figure was -$61.4 million, down 16.29% from the prior year.
- Profit After Tax was -$14.4 million for Q4 2025 at Senti Biosciences Holdings, up from -$18.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$1178.0 in Q1 2021 to a low of -$83.4 million in Q4 2023.
- Historically, Profit After Tax has averaged -$18.8 million across 5 years, with a median of -$14.3 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax tumbled 1002276.91% in 2022, then soared 99.26% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$3.9 million in 2021, then plunged by 1409.17% to -$58.2 million in 2022, then sank by 43.28% to -$83.4 million in 2023, then jumped by 99.26% to -$620000.0 in 2024, then tumbled by 2227.26% to -$14.4 million in 2025.
- The last three Profit After Tax figures came in at -$14.4 million (Q4 2025), -$18.1 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | Senti Biosciences Holdings | 21.76 Mn | 21.76 Mn | - | -14.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.43 Mn |
| Sep 30, 2025 | -18.13 Mn |
| Jun 30, 2025 | -14.73 Mn |
| Mar 31, 2025 | -14.11 Mn |
| Dec 31, 2024 | -620,000.00 |
| Sep 30, 2024 | -28.87 Mn |
| Jun 30, 2024 | -11.20 Mn |
| Mar 31, 2024 | -12.11 Mn |
| Dec 31, 2023 | -83.41 Mn |
| Sep 30, 2023 | -14.92 Mn |
| Jun 30, 2023 | -18.70 Mn |
| Mar 31, 2023 | -18.72 Mn |
| Dec 31, 2022 | -58.21 Mn |
| Sep 30, 2022 | -16.64 Mn |
| Jun 30, 2022 | -11.55 Mn |
| Mar 31, 2022 | -11.81 Mn |
| Dec 31, 2021 | -3.86 Mn |
| Sep 30, 2021 | -11.41 Mn |
| Jun 30, 2021 | -12.01 Mn |
| Mar 31, 2021 | -1,178.00 |